Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
18 November 2011

IN THIS ISSUE
World diabetes day
Annex 16 revisions
GSK innovation fund
FDA approvals

 
One in ten adults diabetic by 2030
World Diabetes Day on 14 November saw the release of the International Diabetic Federation’s (IDF) fifth edition of the Diabetes Atlas, which produced some staggering statistics for future escalation of the disease. More...
 
EMA addresses globalised supply chain issues with Annex 16 revisions
The EMA has released a concept paper for consultation that recommends a revision to Annex 16 of the Guide to Good Manufacturing of Medicinal Products to address more complicated global supply chains and new falsified medicines legislation. More...
 
GSK announces $50-million innovation fund in Canada
GlaxoSmithKline is looking to advance the commercialisation of scientific innovation in Canada with its launch of the GSK Canada Life Sciences Innovation Fund, which was announced at a GSK-hosted event in Toronto last week. More...
 
FDA approves 35 novel medicines in 2011
The FDA has approved 35 novel medicines in fiscal year 2011, including two drugs for late-stage metastatic melanoma and the first drug to treat Hodgkins lymphoma in 30 years. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Optimising topical drug formulations and manufacturing
High court to rule on health reform legality
Two early cancer studies show promise
More blog posts

Latest articles
What's on the box?
Europe prepares to battle the counterfeiters
EFPIA for greater patient safety
More articles

Upcoming events
Downstream Bioprocessing & Single-use Systems Asia 2011 (1 December | Singapore)
FT Global Pharmaceutical and Biotechnology Conference (5–6 December | UK)
Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security (13 December | Webinar)
More events

Product/Service Profiles
Shimadzu

Supersonic flow
Shimadzu's new LCMS-8030 features the most innovative technology found in a commercial tandem quadrupole mass analyzer.  Combined with the class-leading Nexera UHPLC, both systems facilitate seamless LC/MS/MS analyses in a high-performance, high-speed flow, steadily and reliably.
Read More

 
Sterilin

Non-pyrogenic polystyrene containers
Sterilin non-pyrogenic polystyrene containers are certified endotoxin-free to levels below 0.01EU/ml, making them ideal for use in the pharmaceutical industry for the storage of samples, formulation work, sterility testing and endotoxin testing. Sterilized by gamma irradiation, they are available in a wide range of volumes. Read more


Future Podcasts

Vetter's Chicago Facility Fully Operational
In 2010, Vetter brought you up to date on the company’s plans to expand its Vetter Development Service operations by opening its first manufacturing site outside of Germany. Just recently, Vetter announced that the site, located in Chicago at the Illinois Science + Technology Park in Skokie, is fully operational. Read more


Event profiles

Cool Chain Logistics Europe 2012
30th January – 1st February
Basel, Switzerland
Over the past 11 years, CCLE has become the stomping ground for temperature control logistics and QA professionals in Europe to shape ideas for the future. Read more


 
Survey
In your company for 2012, how do you anticipate the level of outsourcing for small-molecule API development and manufacturing will change compared with 2011?
Increase 60%
 
Decrease 12%
     
Stay the same 28%

This week we would like to know...

What is driving manufacturers to reformulate or reinvent currently marketed solid dose pharmaceutical products?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.